Results 101 to 110 of about 180,206 (347)

Relationship between QT interval and ventricular electrical axis: A new suggestion for Lead selection in QT interval measurement [PDF]

Acta Medica Iranica, 2000
Exploration of the interlead QT variation (QT dispersion) introduced cardiologists to some new concepts including the deed to define a standard for lead selection in the measurement of QT interval and the reason or factors contributing to QT dispersion ...
"Moradman S, Hatamizadeh P "
doaj   +2 more sources

Shortening of the Short Refractory Periods in Short QT Syndrome. [PDF]

, 2017
BACKGROUND: Diagnosis of short QT syndrome (SQTS) remains difficult in case of borderline QT values as often found in normal populations. Whether some shortening of refractory periods (RP) may help in differentiating SQTS from normal subjects is unknown.
Cardin, C, Fourcade, C, Gaita, F, Gandjbakhch, E, Giustetto, C, Maupain, C, Maury, P, Mondoly, P, Monteil, B, Rollin, A, Scrocco, C   +10 more
core   +3 more sources

QT Interval Shortening After Bariatric Surgery: Mind the Heart Rate Correction Equation [PDF]

, 2021
Bernd Schultes, Erik Konrad Grasser, Barbara Ernst   +2 more
openalex   +1 more source

Large Language Models for Clinical Trial Protocol Assessments

Clinical Pharmacology &Therapeutics, EarlyView.
The purpose was to evaluate the utility of large language models (LLMs) for reviewing the statistical analysis plan (SAP) and pharmacokinetics–pharmacodynamics (PK–PD) components of clinical trial protocols. Clinical trial protocols and SAPs were obtained from clinicaltrials.gov for a testbed of 15 small‐molecule drugs, biologics, and global antibiotic
Euibeom Shin, Amruta Gajanan Bhat, Murali Ramanathan   +2 more
wiley   +1 more source

The QT interval [PDF]

Circulation, 2019
John R. Giudicessi, Peter A. Noseworthy, Michael J. Ackerman   +2 more
openaire   +2 more sources

Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes

Clinical Pharmacology &Therapeutics, EarlyView.
Potential adverse drug events can be signaled in Clinical Decision Support Systems (CDSSs). This study validated a Swedish CDSS (Janusmed Risk Profile) by investigating associations between calculated risk classifications of drugs with QT‐prolonging potential and registered related clinical outcomes.
Ola Nordqvist, Olof Björneld, Patrick Bergman, Björn Wettermark, Alisa Lincke, Marine L. Andersson, Tora Hammar   +6 more
wiley   +1 more source

QT interval prolongation after sertraline overdose: a case report

BMC Emergency Medicine, 2005
Background Selective serotonin reuptake inhibitors (SSRIs) are the most common antidepressants used in first-world countries and are generally well tolerated.
Holman Nicole D, van Dijk Tonnis H, de Boer Rudolf A, van Melle Joost P   +3 more
doaj   +1 more source

QT Interval in Pregnant and Non-pregnant Women

Archives of Academic Emergency Medicine, 2018
Introduction: Prolongation of QT interval might result in dangerous cardiac arrhythmias, including Torsades de Pointes (TdP), consequently leading to syncope or death.
Majid Zamani, Mehrdad Esmailian, Zahra Yoosefian   +2 more
doaj   +1 more source

Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study [PDF]

, 2007
BACKGROUND: Heritable electrocardiographic (ECG) and heart rate variability (HRV) measures, reflecting pacemaking, conduction, repolarization and autonomic function in the heart have been associated with risks for cardiac arrhythmias.
Guo, Chao-Yu, Larson, Martin G., Levy, Daniel, Newton-Cheh, Christopher, O'Donnell, Christopher J., Wang, Thomas J.   +5 more
core   +4 more sources

Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT‐HF registry

European Journal of Heart Failure, EarlyView.
Global patterns of polypharmacy after acute heart failure hospitalization. GDMT, guideline‐directed medical therapy; HF, heart failure. Aims Polypharmacy, defined as the concurrent use of ≥5 medications, is prevalent among older adults with heart failure (HF).
Wan Ting Tay, Tiew‐Hwa Katherine Teng, Wouter Ouwerkerk, John G.F. Cleland, Sean P. Collins, Christiane E. Angermann, Kenneth Dickstein, Ulf Dahlstrom, Anja Schweizer, Achim Obergfell, Kai‐Hang Yiu, Mathieu Ghadanfar, Mahmoud Hassanein, Qing‐Wen Ren, Wen‐Li Gu, Georg Ertl, Sergio V. Perrone, Gerasimos Filippatos, Carolyn S.P. Lam, Jasper Tromp   +19 more
wiley   +1 more source